Events

BE-ARMA live event
SEP
Tue
17
09:00 - 17:30

This was 1 year ago

Location

KU Leuven

Parkstraat 49, Leuven
Programmes
Horizon Europe Digital Europe

The third BE-ARMA* live event, hosted by KU Leuven, will comprise lectures and discussions about Cybersecurity & AI in Research Management. In the afternoon different break-out sessions will be organised which will give you insights in several topics by peer-to-peer discussions like lump sum funding, Interreg reporting, cybersecurity in research management, ...

The flyer and registration link is already available on the BE-ARMA website. The detailed programme will be published shortly.

 

*BE-ARMA is a network of research managers and administrators in European funded projects, located in Belgium, from all type of organisations, facilitating peer-to-peer learning and exchange of best practices. Consult www.bearma.be for more details and how to join the community.

 

 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.